ATM and neoplasm: Monotherapy with ATM inhibitor 67 did not cause tumor regression in the SW620 colorectal tumor xenograft model, whereas combination with irinotecan resulted in significantly greater tumor growth inhibition in comparison to irinotecan alone [14,73].